Loading
Latest filing published 04 May 2021 for Werewolf Therapeutics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Arkin Bio Ventures 2 L.P. has a single filing on record, published on 4 May 2021: a transaction in Werewolf Therapeutics, Inc. One trade is not enough to describe a pattern. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration